Nanobiotix (NBTX) Short term Debt: 2019-2025
- Nanobiotix's Short term Debt fell 0.46% to $5.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.4 million, marking a year-over-year decrease of 0.46%. This contributed to the annual value of $5.3 million for FY2024, which is 3.14% down from last year.
- Per Nanobiotix's latest filing, its Short term Debt stood at $5.4 million for Q2 2025, which was up 1.86% from $5.3 million recorded in Q4 2024.
- In the past 5 years, Nanobiotix's Short term Debt registered a high of $10.9 million during Q2 2023, and its lowest value of $5.3 million during Q4 2024.
- In the last 3 years, Nanobiotix's Short term Debt had a median value of $5.4 million in 2024 and averaged $6.5 million.
- Its Short term Debt has fluctuated over the past 5 years, first soared by 61.57% in 2021, then slumped by 50.41% in 2024.
- Nanobiotix's Short term Debt (Quarterly) stood at $9.4 million in 2021, then increased by 19.86% to $9.7 million in 2022, then grew by 11.78% to $5.4 million in 2023, then dropped by 2.62% to $5.3 million in 2024, then declined by 0.46% to $5.4 million in 2025.
- Its last three reported values are $5.4 million in Q2 2025, $5.3 million for Q4 2024, and $5.4 million during Q2 2024.
